Federal Register #DEA-1732

DEA Notice: Catalent Pharma Solutions Application to Import Controlled Substances for Research

This opportunity involves the Drug Enforcement Administration (DEA) reviewing an application from Catalent Pharma Solutions, LLC to import controlled substances for research purposes. - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - OEM/Vendor: - Catalent Pharma Solutions, LLC - Products Requested: - Lysergic acid diethylamide (LSD), drug code 7315 - 5-Methoxy-NN-dimethyltryptamine, drug code 7431 - Psilocybin, drug code 7437 - All substances to be imported as finished dosage unit products - Quantities: - Not specified in the notice - Intended Use: - Clinical trials - Research - Analytical activities - Unique Requirements: - Importation strictly for clinical, research, and analytical purposes - No authorization for commercial sale or import of FDA-approved or non-approved finished dosage forms for commercial sale - Registration limited to the specified drug codes - Docket No.: DEA-1732

Description

Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic classes of controlled substances including Lysergic acid diethylamide, 5-Methoxy-NN-dimethyltryptamine, and Psilocybin. The company plans to import these substances as finished dosage unit products for clinical trials, research, and analytical activities. No other activities for these drug codes are authorized for this registration. Comments on the application are due by July 30, 2026.

View original listing